Peptide record

TPDB92466

Rev (34-50) Antibacterial Antiviral Cell-penetrating Peptides modified_plain modified
17 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92466
Rev (34-50)
Antibacterial Antiviral Cell-penetrating Peptides
Anti-infective peptides Delivery and barrier-penetrating peptides
Peptipedia AI4AVP dbAMP 3.0 DRAVP 2.0 CellPPD CPPsite3.0 PerseuCPP
modified_plain
Yes
A 17-aa modified multi-activity (Antibacterial, Antiviral, and Cell-penetrating Peptides) peptide sequence curated from Peptipedia, AI4AVP, dbAMP 3.0, and other sources, with an available 3D structural model.
C-terminal: Conjugation with fluorescein by C-terminal Cys amide
Sequence
TRQARRNRRRRWRERQR
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
17 reviewed residue count
Conjugation with fluorescein by C-terminal Cys amide Activity
L Activity
Cationic Activity
Linear Activity
Free Activity
N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC1=C(C(=NC1)C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)O Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Cell-penetrating Peptides

Target

RAW 264.7

Source & Reference

CPPsite3.0
CPPsite3
US 20060223752

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Natural residues Linear L Cationic
Protein derived
Fluorophore (fluorescein)
Cytoplasm and nucleus
High (comparable to Tat (48-60)
Non-endocytic mechanism
In vitro
CCCCTTTHHHHHHHTCC
Additional Detail Fields 1 fields
CCCCTTTHHHHHHHTCC